Skip to main navigation Skip to search Skip to main content

Phase 111b, Double-Blinded, Multicenter Study to Evaluate The Efficacy and Safety of Alteplase in Patients With Mild Stroke: Rapidly Improving Symptoms And Minor Neurologic Deficits

Project: Research

Project Details

StatusFinished
Effective start/end date01/20/14 → 12/31/18

Funding

  • Genentech Incorporated: $24,643.50